Medical technology3 min read
Deep brain stimulation and neurostimulation
DBS
Deep brain stimulation treats symptoms of some movement disorders such as Parkinson’s disease, essential tremor and dystonia, and is also used for epilepsy. Leads in the brain are connected to a battery that sends electrical pulses. The FDA first approved it in 1997; it is not a cure.
According to NINDS, deep brain stimulation for epilepsy was approved in 2018, and "responsive neurostimulation" was approved in 2013 for adults with drug-resistant focal epilepsy; it stimulates only when continuously monitored brain activity indicates the start of a seizure. The FDA recently approved an adaptive deep brain stimulation system for Parkinson's disease.
Stimulation helps control symptoms but does not slow the progression of neurodegeneration. In rare cases, placing the device may cause bleeding or infection in the brain. Its use for other conditions is being studied in clinical trials only. Related research includes brain–computer interfaces.
- In widespread clinical use
- Approved for specific uses
- In clinical trials
- Preclinical
- Concept
FDA-approved since 1997 for the symptoms of some movement disorders, and later for types of epilepsy.
- Movement disorders (Parkinson's, essential tremor, dystonia)Approved for specific uses
First approval in 1997, and a recent adaptive system for Parkinson's.1
- Drug-resistant epilepsyApproved for specific uses
Responsive neurostimulation (2013) and deep brain stimulation for epilepsy (2018).2
Status last checked: · What the maturity levels mean
What is it?
Deep brain stimulation is a treatment for the symptoms of some movement disorders, including muscular dystonia, essential tremor and Parkinson's disease.
How does it work?
An implanted battery generates electrical pulses that travel along a wire to an electrode in the brain.
Responsive neurostimulation stimulates only when continuously monitored brain activity indicates the start of an epileptic seizure.
Where is it used today?
The FDA first approved it in 1997, and it is used for the symptoms of Parkinson's disease, essential tremor and dystonia, and for epilepsy.
Responsive neurostimulation has been approved since 2013 for adults with drug-resistant focal epilepsy, and deep brain stimulation for epilepsy since 2018.
Limits and risks
A powerful tool for treating movement disorders, but not a cure, and it does not slow the progression of neurodegeneration.
In rare cases, placing the device may cause bleeding or infection in the brain.
Common questions
Does deep brain stimulation cure Parkinson's disease?
No. It helps control symptoms, and does not slow the progression of neurodegeneration.1
Questions for your doctor
- Are my symptoms of a type that responds to deep brain stimulation?
- What are the risks of the surgery, and how are the settings adjusted afterwards?
References
- 1NINDS (NIH). Deep Brain Stimulation (DBS). www.ninds.nih.gov/health-information/disorders/deep-brain-stimulation-dbsHealth agencies & guidelines · Accessed 2026-10-08
- 2NINDS (NIH). Brain stimulation therapies for epilepsy. www.ninds.nih.gov/about-ninds/what-we-do/impact/ninds-contributions-approved-therapies/brain-stimulation-therapies-epilepsyHealth agencies & guidelines · Accessed 2026-10-08
Review status: Edited content · Last updated:
Change log
- — Page created.
Educational content only — no diagnosis, and no substitute for a clinician.